Avance Clinical’s Director, Asian Operations, Jessica Han; Associate Director, Operations Taiwan, Kelly Yang; SE Asia, Scientific and Regulatory Affairs Senior Specialist, Hee NamGung; Associate Director, Business Development, James Lumicisi; and Director of Strategic Partnerships, Robert Jones, will be attending and available for partnering meetings at BIO KOREA 2025.
Jessica Han, based in Seoul, brings over 18 years of experience in healthcare and clinical research. As Director of Asian Operations, her leadership is instrumental in driving Avance Clinical’s regional strategy and operational excellence across Asia.
Kelly Yang, with over 15 years in the pharmaceutical and clinical research industries, leads Avance Clinical’s operations in Taiwan. Her strong background in clinical operations and project management reinforces our capabilities and local execution in the region.
Recently, Avance Clinical formalized strategic partnerships with leading Korean institutions, including CHA University Bundang Medical Center, Korea University Medicine, and Dong-A University Hospital. These Memorandums of Understanding (MOUs) strengthen Avance Clinical’s capacity to offer flexible and high-quality clinical trial services across the Asia-Pacific region.
Jessica Han said, “Avance Clinical’s participation in BIO KOREA 2025 underscores our commitment to advancing clinical research in South Korea and across the broader Asia region. We look forward to meaningful engagement with industry leaders and uncovering new opportunities to drive innovation and growth in the bio-health sector.”
Avance Clinical offers a seamless solution for biotechs looking for a CRO partner with deep experience in regulatory strategy and site relationships across Asia, North America, Australia and New Zealand. Clients benefit from rapid start-up and patient recruitment, with global quality data accepted by all major regulatory authorities including the FDA and EMA. The Asia-Pacific region is increasingly attractive due to the patient recruitment advantages, high-quality data, and advanced medical infrastructure in countries such as South Korea.
The team will be at Booth B1 during the event.
